XBiotech Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for XBiotech Inc. (XBIT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2018
Operating Activities
Net Income-38.53-24.56-32.90-17.41-11.22-21.14
Depreciation & Amortization1.751.742.612.652.242.43
Stock Based Compensation1.753.265.064.4612.580.00
Change in Working Capital-1.462.727.6079.75-68.750.51
Change in Accounts Receivable0.080.000.004.11-4.110.00
Change in Accounts Payable-0.360.090.36-0.30-0.330.00
Change in Other Working Capital-0.992.09-0.6576.91-3.980.00
Other Operating Activities5.53-1.892.800.000.000.00
Net Cash from Operating Activities-30.96-18.73-14.8269.45-65.15-16.54
Investing Activities
Capital Expenditures-1.30-0.36-0.59-3.53-3.73-0.12
Purchases of Investments0.0061.86-63.310.000.000.00
Sales/Maturities of Investments0.0061.860.000.000.000.00
Net Cash from Investing Activities-1.3061.50-63.89-3.53-3.73-0.12
Financing Activities
Debt Repayment10.250.000.000.000.000.00
Common Stock Issued0.200.010.008.0010.280.00
Common Stock Repurchased0.000.000.000.00-420.000.00
Dividends Paid0.000.000.00-75.000.000.00
Other Financing Activities0.20-0.010.000.000.000.00
Net Cash from Financing Activities10.45-0.010.00-67.01-409.720.20
Summary
Effect of Forex Changes on Cash-5.53-0.05-0.960.710.000.51
Net Change in Cash-27.3542.72-79.68-1.09-477.23-16.46
Cash at Beginning of Period200.02157.31236.98237.370.0031.77
Cash at End of Period172.68200.02157.31236.980.0015.82
Free Cash Flow-32.27-19.09-15.4165.92-68.88-16.66
Supplemental Disclosures
Interest Paid0.400.000.000.000.000.00
Income Taxes Paid0.090.140.000.0054.090.00